3Sirotnak FM. Studies with ZD1839 in preclinical models[J]. Semin Oncol, 2003,30 (Suppl 1):12 - 20. 被引量：1
4Ritter CA, Arteaga CL. The epidermal growth factor receptor - tyrosine kinase:A promising therapeutic target in solid tumors[J]. Semin Oncol,2003,30(Suppl 1) :3 - 11. 被引量：1
5Schiller JH. New directions for ZD1839 in the treatment of solid tumors[ J ]. Semin Oncol, 2003,30 (Suppl 1): 49 - 55. 被引量：1
6Lorusso PM, Herbst RS, Rischin D, et al. Improvements in quality of life and disease- related symptoms in phase Ⅰ trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors[J ]. Clin Cancer Res, 2003,9(6): 2040 - 2048. 被引量：1
